Literature DB >> 8507809

Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review.

R Vanholder, S Ringoir.   

Abstract

Infectious diseases remain among the most morbid events and are an important cause of death in ESRD. These events are related to an acquired immunodeficiency that progresses during the development of uremic retention, as part of the broader spectrum, displayed by the "uremic syndrome". A central role in the hose defense against bacterial infection is played by the phagocytic polymorphonuclear white blood cells, which are characterized by the capacity to ingest bacteria (phagocytosis), which is followed by the destruction of those bacteria (killing capacity). This article reviews the mechanisms of development and the potential causes that have been held responsible for this aspect of the defective immune function. The observed changes are attributed to alterations in receptor expression, although more convincing evidence points in the direction of metabolic functional disturbances, especially in the NAD(P)H-oxidase-dependent production of oxygen free radicals. The most important causative factors are: uremic toxicity, iron overload, renal anemia, dialyzer bioincompatibility, and the type of renal replacement therapy. It is concluded that the phagocytic defect in ESRD is multifactorial and that each factor should be managed by specific therapeutic approaches.

Entities:  

Mesh:

Year:  1993        PMID: 8507809     DOI: 10.1681/ASN.V391541

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  42 in total

1.  Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1.

Authors:  Asada Leelahavanichkul; Yuning Huang; Xuzhen Hu; Hua Zhou; Takayuki Tsuji; Richard Chen; Jeffrey B Kopp; Jürgen Schnermann; Peter S T Yuen; Robert A Star
Journal:  Kidney Int       Date:  2011-08-10       Impact factor: 10.612

2.  Destructive pneumococcal septic arthritis in end-stage renal disease.

Authors:  I F Ciernik; J C Gerster; P Burckhardt
Journal:  Clin Rheumatol       Date:  1997-09       Impact factor: 2.980

3.  In vitro effect of cefodizime, imipenem/cilastatin and co-trimoxazole on dexamethasone and cyclosporin A depressed phagocytosis.

Authors:  A Dhondt; R Vanholder; M A Waterloos; G Glorieux; R De Smet; S Ringoir
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

4.  Impaired T cell proliferation, increased soluble death-inducing receptors and activation-induced T cell death in patients undergoing haemodialysis.

Authors:  H J Ankersmit; R Deicher; B Moser; I Teufel; G Roth; S Gerlitz; S Itescu; E Wolner; G Boltz-Nitulescu; J Kovarik
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

5.  Long-term follow-up characteristics of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) receiving chronic hemodialysis at a single center.

Authors:  Yoei Miyabe; Kazunori Karasawa; Tomo Takabe; Shota Ogura; Naoko Sugiura; Mizuki Kyoda; Wataru Ono; Kenichi Akiyama; Nobue Tanaka; Takahito Moriyama; Norio Hanafusa; Keiko Uchida; Ken Tuchiya; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2019-10-22       Impact factor: 2.801

Review 6.  The immunoregulatory function of vitamin D: implications in chronic kidney disease.

Authors:  Kevin A Sterling; Parham Eftekhari; Matthias Girndt; Paul L Kimmel; Dominic S Raj
Journal:  Nat Rev Nephrol       Date:  2012-05-22       Impact factor: 28.314

7.  IκB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in CKD.

Authors:  Jianmin Chen; Julius E Kieswich; Fausto Chiazza; Amie J Moyes; Thomas Gobbetti; Gareth S D Purvis; Daniela C F Salvatori; Nimesh S A Patel; Mauro Perretti; Adrian J Hobbs; Massimo Collino; Muhammad M Yaqoob; Christoph Thiemermann
Journal:  J Am Soc Nephrol       Date:  2016-05-06       Impact factor: 10.121

Review 8.  Paradigms of acute kidney injury in the intensive care setting.

Authors:  John A Kellum; John R Prowle
Journal:  Nat Rev Nephrol       Date:  2018-01-22       Impact factor: 28.314

9.  Predominant effect of kidney disease on mortality in Pima Indians with or without type 2 diabetes.

Authors:  Meda E Pavkov; Peter H Bennett; Maurice L Sievers; Jonathan Krakoff; Desmond E Williams; William C Knowler; Robert G Nelson
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

Review 10.  Management of invasive candidiasis in critically ill patients.

Authors:  Stijn Blot; Koenraad Vandewoude
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.